United Therapeutics Corporation (UTHR)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	1,184,900	1,100,400	1,087,700	976,100	979,700	973,900	888,300	908,700	555,900	451,400	443,800	362,100	593,600	591,800	554,100	635,000	-187,600	-119,600	-153,400	-157,400
Total assets	US$ in thousands	7,167,000	7,023,600	6,681,300	6,346,000	6,044,500	5,781,600	5,543,300	5,359,800	5,169,100	5,048,900	4,844,900	4,641,000	4,615,000	4,411,200	4,219,400	4,025,900	3,913,400	3,999,600	3,898,900	3,726,700
Operating ROA		16.53%	15.67%	16.28%	15.38%	16.21%	16.84%	16.02%	16.95%	10.75%	8.94%	9.16%	7.80%	12.86%	13.42%	13.13%	15.77%	-4.79%	-2.99%	-3.93%	-4.22%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $1,184,900K ÷ $7,167,000K
= 16.53%

The operating return on assets (operating ROA) for United Therapeutics Corp has been relatively stable and consistently positive over the past eight quarters, ranging from 15.38% to 16.95%. This indicates that the company has been effective in generating operating income from its assets. The fluctuations in operating ROA are within a relatively narrow range, suggesting that the company's asset utilization and operating efficiency have been fairly consistent. Overall, United Therapeutics Corp appears to be efficiently utilizing its assets to generate operating profits, which is a positive sign for investors and stakeholders.